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Factors Associated With the Number of Lesions
Excised for Each Skin Cancer
A Study of Primary Care Physicians in Queensland, Australia
Peter D. Baade, PhD; Philippa H. Youl, MPH; Monika Janda, PhD;
David C. Whiteman, PhD; Christopher B. Del Mar, MD; Joanne F. Aitken, PhD
Objective: To assess physician, patient, and skin le-
sion characteristics that affect the number of benign skin
lesions excised by primary care physicians for each skin
cancer.
Design:Prospective study collecting clinical, patient, and
histopathologic details of excisions or biopsies of skin
lesions by random samples of primary care physicians.
Setting: SoutheastQueensland involving traditional fam-
ily medicine physicians (n=104; response rate,53.9%)
and family medicine physicians working in 27 primary
care skin cancer clinics (n=50; response rate,75.0%).
Participants:Of 28755 skin examinations recorded dur-
ing the study, 11 403 skin lesions were excised or biop-
sied; 97.5% of the excised lesions had clinical and his-
tologic diagnoses recorded.
Main OutcomeMeasures: Number of lesions needed
to excise or biopsy (NNE) for 1 melanoma (pigmented
lesions only) and NNE for 1 nonmelanoma skin cancer
(nonpigmented lesions only).
Results: The NNE for nonpigmented lesions (n=8139)
was 1.5 (95% confidence interval, 1.4-1.6) and for pig-
mented lesions (n=2977)was 19.6 (16.2-22.9). TheNNE
estimateswere up to 8 times lower if the physician thought
the lesion was likely to be malignant and up to 2.5 times
higher if there was strong patient pressure to excise. The
NNE estimates varied by other physician-, patient-, and
lesion-related variables.
Conclusions: Clinical impressions of excised skin le-
sions were strongly associated with NNE estimates. By
focusing on pigmented skin lesions and by addressing
the physician- and patient-specific factors identified, the
effectiveness of future training for primary care physi-
cians in the clinical management of skin cancer could be
improved.
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S KIN CANCER IS THEMOST COM-mon cancer in countries withpredominantly fair-skinnedpopulations,1 and it is a sig-nificant and increasing pub-
lic health issue.2-5 Australia has the high-
est incidence rates of nonmelanoma skin
cancer (NMSC), an order of magnitude
greater than in other countries.3,6 In par-
ticular, Queensland, the northeastern state
of Australia, has the highest incidence of
melanoma in the world.6,7
Early diagnosis of skin cancer requires
an ability to differentiate between benign
and malignant lesions. In Australia, most
skin cancer is diagnosed and treated by pri-
mary care physicians, so their ability to di-
agnose skin lesions is crucial.8
Physicians presented with a suspi-
cious skin lesion will use clinical reason-
ing9,10 to decide the appropriate course of
action. The decision to excise or biopsy a
skin lesion is based on the perceived im-
plications of treating vs not treating the le-
sion. Factors that affect this decision in-
clude the clinical diagnosis of the skin
lesion; the degree of uncertainty about its
malignant potential; the desire to notmiss
a malignant lesion11,12; patient-related is-
sues, including insisting that the lesion be
removed13; physician-related issues, such
as experience12; and the economic conse-
quences, including benefits to the physi-
cian of performing excisions.14
Mainlybecauseof itshigh incidence, skin
cancerwas the single biggest contributor to
cancer-related health costs in Australia in
2001, costing $262 million (in US cur-
rency),or approximately$14.60percapita.15
It ranked fifth in theUnited States,16 the an-
nual expenditure forNMSCbeing$650mil-
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lion in 199517 and for melanoma being $560 million,18
which, when combined, equates to approximately $4.60
per capita. Skin cancer is also having increasing economic
impact in Europe2; recent estimates for Germany suggest
that hospitalizations due to skin cancer in 2003 cost $281
million, or approximately $3.40 per capita.19 Much of the
economic burden is caused by excisions andbiopsies of be-
nign lesions. Between 2001 and 2005, the rate of diagnos-
tic biopsies increased inQueensland by 130%, yet the rate
of NMSC increased by only 28%.20 Published studies have
reported that up to 31pigmented lesions are excised bypri-
mary care physicians for 1 confirmed melanoma8,14,21 and
up to2nonpigmented skin lesions for1 confirmedNMSC.22
Therefore, there seems to be scope for reducing the eco-
nomic impact associatedwith themanagement of skin can-
cer by reducing the excision of benign lesions. It is un-
clear what clinical-, lesion-, and patient-related factors are
associatedwith higher rates of benign excisions. It was the
aim of this large, prospective study of primary care physi-
cians in thehigh incidencepopulationof southeastQueens-
land to assess the impact that specific treating physician,
patient, and lesion characteristics had on the number of
lesions (treatingpigmentedandnonpigmented lesions sepa-
rately) needed to excise or biopsy (NNE) to detect a ma-
lignant skin lesion.
METHODS
This study, conducted in 2005, was designed to examine details
of skin lesions excised or biopsied by family medicine physi-
cians (FMPs) and those FMPs working solely in the field of skin
cancer (hereafter “skin cancer physicians”) in primary care skin
cancer clinics in southeast Queensland. These clinics are open
access and are staffed byFMPswhohave a specific interest in skin
cancer medicine. The fieldwork methods used for this study are
described in detail elsewhere,23 with a summary provided herein.
AUniversityofQueenslandethicscommitteeapprovedthisstudy.
Participatingphysiciansprospectively recordeddetails of all con-
sultations involving patients undergoing a skin examination. Be-
cause,bydefinition,aclinicalandahistologicdiagnosisarerequired
on all lesions to estimate theNNE, this article focuses on consul-
tations in which a lesion was excised or biopsied.
SAMPLE SELECTION
A sample of FMPs (n=200)working inmainstreamgeneral prac-
tice were randomly selected and invited to participate. Nonre-
spondentswere sent a reminder letter, and, if required, theywere
contacted by telephone at 2-week intervals. A total of 104 (53.9%
of 193 eligible) FMPs participated in the study. Skin cancer phy-
sicians from 36 eligible primary care skin cancer clinics in the
study area were similarly contacted. Twenty-seven skin cancer
clinics (75.0%)participated in the study, representing50 skin can-
cer physicians.
DATA COLLECTION
Each participating physician was asked to provide data on age,
sex, year of graduation, location of training, years of experience
working as a skin cancer physician or an FMP, type of fellow-
ship, any additional training since graduation (including train-
ing in skin cancer diagnosis), and whether they use equipment
to aid diagnosis in their day-to-day practice (response categories
are given in Table 1).
Data collection for FMPs was split across two 8-week peri-
ods. Because the volume of skin examinations was known to be
higher in skin clinics than in general practice,21,24 we split data
collection for skin cancer physicians across two 4-week periods.
Physicians completed case report forms for all consulta-
tions involving a skin examinationduring the studyperiod. Items
on the case report forms (response categories are given in
Table 1) for these consultations included type of skin exami-
nation, who initiated the examination, and basic demograph-
ics (age and sex) of the patient. When physicians excised or
biopsied a lesion, they recorded the site of the lesion, whether
the treatment was a planned surgical procedure or a reexci-
sion, their provisional diagnosis, the likelihood of malig-
nancy, and the degree of patient pressure to excise. Trained re-
search staff extracted histologic diagnosis, body site, andwhether
the lesion was “excised” or “biopsied” from pathology reports
at physicians’ practices for each excised and biopsied skin le-
sion. Excisions were defined as all surgical procedures where
the entire lesionwas removed, regardless of the instrument used
(eg, scalpel and curette); biopsies were defined as all surgical
procedures in which part of the lesion was removed for the pri-
mary purpose of histologic diagnosis. These were predomi-
nantly “punch biopsies” or “shave biopsies.” Lesions that were
biopsied and later excised were counted only once, based on
the first surgical procedure (ie, biopsy).
The diagnosis of lesions was grouped into 9 categories: mela-
noma (including lentigomaligna), squamous cell carcinoma (in-
cluding keratoacanthoma and intraepidermal carcinoma), basal
cellcarcinoma,solarkeratosis,dysplasticnevus,benignnevus,other
pigmentedbenign lesions(includingseborrheickeratosis, lichen-
oid keratosis, and solar lentigo), other benign lesions (including
cyst,dermatofibroma,andhemangioma), andothermalignant le-
sions (including mycosis fungoides and sebaceous carcinoma).
ANALYSIS
The analysis focused on factors associated with the number of
skin lesionsexcisedorbiopsied for1malignant lesion.TheNNE14,25
is an epidemiologicmeasure of diagnostic accuracy calculated by
dividing the total number of lesions excised or biopsied by the
number of those lesions confirmed by histologic examination as
beingmalignant. Estimates ofNNEwere calculated separately for
pigmented lesions (melanoma, dysplastic nevi, benign nevi, and
otherpigmentedbenign lesions,withmalignant lesionsbeingmela-
noma) and nonpigmented lesions (NMSC, solar keratosis, and
other benignnonpigmented lesions,withmalignant lesions being
NMSC, including squamous cell carcinoma and basal cell carci-
noma). Analyses were conducted using Stata 9.2 (StataCorp LP,
College Station, Texas).
All the analyses accounted for the multistage sampling de-
sign, including the sampling by physicians and the selection
of multiple skin clinic physicians in the same clinic. We trans-
formed the parameter estimates from a standard logistic re-
gression model (using the formula eo/[1eo]) to calculate
the subgroup-specific NNE, along with 95% confidence inter-
vals using the nlcom command in Stata.
The NNE ratio represents the ratio of the NNE for 1 popula-
tion subgroup divided by the NNE for the reference population
subgroup. The NNE ratios were derived from a standard logistic
regressionmodelusing the transformation (eo1x1/[1eo1x1])
/(eo/[1eo]). These ratios, and their 95% confidence inter-
vals, were obtained using the nlcom command in Stata.
The NNE ratios were adjusted for a range of clinical and pa-
tient-related variables (Table 1 and Table 2). We initially in-
cluded all covariates in the logistic regression model and then
manually refined the model by excluding nonsignificant vari-
ables based on a conservative significance level of P .25. We
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assessed the significance of covariates in themultivariatemodel
by testing the hypothesis that all the category-specific vari-
ables of the covariate were equal to zero. The choice of base-
line reference categories for theNNE ratios wasmade on the ba-
sis of cell sizes (reference category had the largest cell size) or,
in some cases, to facilitate easier interpretation.
For 3 variables—likelihood of malignancy, level of patient
pressure, and who initiated the consultation—3% to 6% of the
records had missing responses. To prevent these records from
being deleted from the logistic models, we included a separate
category (“no response”) for these variables. Significance of es-
timates did not include this “no response” category.
RESULTS
Of 28 755 skin examinations recorded during the study,
11 403 skin lesions were excised or biopsied. The mean
age of patients who had an excision or a biopsy was 58
years compared with 51 years for patients who had a skin
examination only. The proportion ofmale and female pa-
tients who had a skin excision or biopsy was 57.2% and
42.8%, respectively. Of these excised lesions, 11 116
(97.5%) had clinical and histologic diagnoses available for
analysis. Approximately a third (33.6%) of the participat-
ing physicians were women, and themean number of ex-
cisions per physician was 73 (median, 34; range, 1-741).
Almost half of the excised lesions (48.8%) were his-
tologically confirmed as NMSC (squamous cell carci-
noma, 17.8%; basal cell carcinoma, 31.0%), 12.9% were
solar keratoses, 9.4% were benign nevi, 5.4% were dys-
plastic nevi, 10.6% were other pigmented benign le-
sions, 11.4% were other benign lesions, and 1.4% were
melanomas. Only 9 lesions (0.1%) were grouped un-
der other malignant lesions. More than a quarter of the
excised lesions (26.8%)were pigmented. There were 754
Table 1. Associations Among Various Physician-, Lesion-, and Patient-Related Characteristics and the NNE:
NMSC (Including BCC and SCC) vs All Nonpigmented Lesions
Variable and Categories
Nonpigmented
Lesions, No.
NNE Estimate
(95% CI)a P Value
Adjusted NNE Ratios
(95% CI)b P Value
Total 8139c 1.5 (1.4-1.6)
Physician-Related Characteristics
Sex
Male 6676 1.5 (1.4-1.5)
.001
1 [Reference]
.008
Female 1463 1.7 (1.6-1.8) 1.24 (1.03-1.45)
Age group, y
35 676 1.5 (1.2-1.7)
.57
1.04 (0.63-1.46)
.02
35-44 2339 1.5 (1.4-1.5) 0.85 (0.61-1.08)
45-54 3519 1.5 (1.4-1.6) 0.80 (0.62-0.98)
55 1605 1.5 (1.4-1.6) 1 [Reference]
Physician type
General practitioner 2160 1.5 (1.4-1.6)
.85 Not in final model NA
Skin clinic physician 5979 1.5 (1.4-1.6)
Graduated
Australia 7227 1.5 (1.4-1.5)
.003
1 [Reference]
.001
Overseas 912 1.7 (1.5-1.9) 1.31 (1.12-1.51)
Fellowship
FRACGP 3272 1.5 (1.4-1.6)
.15 Not in final model NA
Other/none 4867 1.5 (1.4-1.5)
Additional training
Yes, skin cancer 3423 1.6 (1.5-1.7)
.003 Not in final model NAYes, other 1702 1.5 (1.4-1.6)
None 3014 1.4 (1.4-1.5)
CPD
Yes 6654 1.5 (1.4-1.6)
.88
1 [Reference]
.12
No 1485 1.5 (1.4-1.6) 1.09 (0.97-1.22)
Vocationally registered
Yes 3435 1.5 (1.4-1.6)
.64
0.87 (0.77-0.98)
.02
No 4704 1.5 (1.4-1.6) 1 [Reference]
Sessions at current practice, No./wk
6 1008 1.4 (1.4-1.5)
.21 Not in final model NA
6 7131 1.5 (1.4-1.6)
Equipment available at practice
Dermatoscope 4052 1.6 (1.5-1.7)
.007
1 [Reference]
.07Computer imaging 3044 1.4 (1.4-1.5) 0.84 (0.71-0.97)
None 1043 1.5 (1.4-1.6) 0.92 (0.72-1.13)
Experience after graduation, y
15 1694 1.6 (1.4-1.7)
.62
1 [Reference]
.21
15-24 3109 1.5 (1.4-1.5) 1.18 (0.91-1.44)
25-34 2144 1.5 (1.4-1.6) 1.27 (0.93-1.61)
35 1192 1.5 (1.4-1.6) 1.06 (0.67-1.45)
(continued)
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seborrheic keratoses (6.7%) included in the other pig-
mented benign lesions category.
NONPIGMENTED LESIONS
There were 8139 nonpigmented lesions excised or biop-
sied during the study, of which 5431 were NMSC. The
overall NNE for nonpigmented lesionswas 1.5 (95% con-
fidence interval, 1.4-1.6). That is, 1.5 nonpigmented skin
lesionswere excised or biopsied to identify 1NMSC. Phy-
sicians who graduated overseas and those with no voca-
tional registration were independently associated with
higherNNE estimates (Table 1). Age of the physicianwas
not consistently associated with higher or lower NNE for
nonpigmented lesions. We found no significant inde-
pendent association between NNE and any of the re-
maining characteristics of physicians.
Physicians initially diagnosed 34.0% of excised
nonpigmented lesions as being very likely to be malig-
nant, and these made up 46.2% of confirmed NMSCs,
whereas 15.6% had low likelihood of malignancy, and
these composed 6.8% of confirmed NMSCs. Initial
diagnoses of very likely to be malignant were signifi-
cantly associated with lower NNEs than were lesions
Table 1. Associations Among Various Physician-, Lesion-, and Patient-Related Characteristics and the NNE:
NMSC (Including BCC and SCC) vs All Nonpigmented Lesions (cont)
Variable and Categories
Nonpigmented
Lesions, No.
NNE Estimate
(95% CI)a P Value
Adjusted NNE Ratios
(95% CI)b P Value
Lesion-Related Characteristics
Likelihood of malignancy
Not at all likely 582 5.8 (4.2-7.3)
.001
1 [Reference]
.001
2 690 2.6 (2.3-2.9) 0.47 (0.33-0.60)
3 1769 2.0 (1.8-2.1) 0.39 (0.26-0.52)
4 2083 1.4 (1.3-1.5) 0.33 (0.20-0.45)
Very likely 2766 1.1 (1.1-1.1) 0.29 (0.16-0.41)
No response 249d 1.5 (1.3-1.6) 0.35 (0.22-0.48)
Patient pressure to excise
No pressure 3621 1.4 (1.4-1.5)
.001
1 [Reference]
.001
2 903 1.5 (1.4-1.6) 1.08 (0.94-1.12)
3 1171 1.6 (1.5-1.6) 1.18 (1.08-1.28)
4 982 1.6 (1.4-1.7) 1.30 (1.09-1.50)
Strong pressure 988 1.8 (1.6-1.9) 1.56 (1.35-1.78)
No response 474d 1.4 (1.4-1.5) 0.97 (0.78-1.16)
Initiated
By physician 2137 1.4 (1.3-1.4)
.001 Not in final model NA
Patient: primary reason 5050 1.6 (1.5-1.6)
Patient: secondary reason 513 1.5 (1.4-1.7)
No response 439d 1.4 (1.3-1.5)
Examination typed
Whole body 3721 1.6 (1.5-1.7)
.001 Not in final model NAPart body 1150 1.5 (1.4-1.5)
Specific lesions 3143 1.4 (1.4-1.5)
Excision type
Excision 4254 1.3 (1.2-1.3)
.001
1 [Reference]
NA
Biopsy 3837 1.9 (1.8-1.9) 2.19 (1.91-2.46)
Site
Head 3124 1.5 (1.5-1.6)
.001
1 [Reference]
.005
Arm 1973 1.5 (1.4-1.6) 0.98 (0.90-1.06)
Leg 1344 1.6 (1.5-1.7) 0.94 (0.82-1.06)
Chest 570 1.5 (1.4-1.6) 0.88 (0.73-1.02)
Back 1127 1.3 (1.3-1.4) 0.74 (0.62-0.86)
Patient-Related Characteristics
Sex
Male 4887 1.4 (1.4-1.5)
.001
1 [Reference]
.03
Female 3240 1.6 (1.5-1.7) 1.09 (1.00-1.19)
Age, y
50 1473 1.7 (1.6-1.8)
.001
1.22 (1.09-1.34)
.001
50 6656 1.5 (1.4-1.5) 1 [Reference]
Abbreviations: BCC, basal cell carcinoma; CI, confidence interval; CPD, continuing professional development; FRACGP, Fellow of the Royal Australian College of
General Practitioners; NA, not applicable; NMSC, nonmelanoma skin cancer; NNE, number of nonpigmented lesions needed to excise or biopsy; SCC, squamous
cell carcinoma.
aFor nonpigmented lesions, the NNE is the number of excisions or biopsies of lesions divided by the number of NMSCs excised.
bRatios reflect the NNE in the specific category divided by the NNE in the reference category. The NNE ratios were adjusted for all other variables in the table,
except where specified. Variables were deleted from the multivariate model in a backward selection process based on P .25.
cThe number of nonpigmented lesions do not total 8139 for some categories because of incomplete records: for examination type there were 125 records with
missing values; for excision type, 48 records; for site, 1 record; and for sex, 12 records.
dThe “no response” category was not included in the tests of statistical significance.
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classified as not at all likely to be malignant (Table 1).
High levels of patient pressure were significantly asso-
ciated with higher estimates of NNE (Table 1). Higher
estimates of NNE for nonpigmented lesions were also
associated with lesions initially biopsied rather than
excised, whereas lower NNEs were observed for
lesions excised from the back. Lesions from females
and younger patients were associated with higher
NNEs (Table 1).
PIGMENTED LESIONS
There were 2977 pigmented lesions diagnosed, of which
152 were histologically confirmed to be melanoma. The
overall NNE for pigmented lesions was 19.6 (95% con-
fidence interval, 16.2-22.9) (Table 2). When we ex-
cluded the 55 in situ malignant lesions, the NNE for pig-
mented lesions increased to 30.7 (95%confidence interval,
24.1-37.3).
Table 2. Associations Among Various Physician-, Lesion-, and Patient-Related Characteristics and the NNE:
Melanomas vs All Pigmented Lesions
Variable and Categories
Pigmented
Lesions, No.
NNE Estimates
(95% CI)a P Value
Adjusted NNE Ratios
(95% CI)b P Value
Total 2977c 19.6 (16.2-22.9)
Physician-Related Characteristics
Sex
Male 2177 17.0 (13.9-20.2)
.001
1 [Reference]
.009
Female 800 33.3 (21.7-44.9) 1.91 (1.23-2.58)
Age group, y
35 297 16.5 (10.0-23.0)
.69 Not in final model NA
35-44 733 19.8 (12.5-27.1)
45-54 1365 19.2 (14.5-23.9)
55 582 22.4 (15.0-29.8)
Physician type
General practitioner 1015 20.7 (14.4-27.0)
.65 Not in final model NA
Skin clinic physician 1962 19.0 (14.9-23.1)
Graduated
Australia 2527 18.9 (15.7-22.1)
.41
1 [Reference]
.19
Overseas 450 25.0 (8.5-41.5) 1.34 (0.74-1.93)
Fellowship
FRACGP 1342 20.6 (15.4-25.9)
.57 Not in final model NA
Other/none 1635 18.8 (14.7-22.9)
Additional training
Yes, skin cancer 1174 19.2 (15.0-23.5)
.96 Not in final model NAYes, other 657 20.5 (12.8-28.3)
None 1146 19.4 (13.8-25.0)
CPD
Yes 2588 19.8 (16.4-23.1)
.80 Not in final model NA
No 389 18.5 (9.3-27.8)
Vocationally registered
Yes 1279 24.6 (18.9-30.2)
.02 Not in final model NA
No 1698 17.0 (13.3-20.7)
Sessions at current practice, No./wk
6 502 20.9 (14.8-27.0)
.64 Not in final model NA
6 2475 19.3 (15.7-23.0)
Equipment available at practice
Dermatoscope 1371 22.1 (16.8-27.5)
.21 Not in final model NAComputer imaging 1134 16.4 (12.2-20.7)
None 472 22.5 (11.5-33.5)
Experience since graduating, y
15 598 18.1 (12.0-24.3)
.88 Not in final model NA
15-24 1181 19.7 (13.9-25.4)
25-34 851 21.3 (14.2-28.4)
35 347 18.3 (12.6-24.0)
Lesion-Related Characteristics
Likelihood of malignancy
Not at all likely 692 86.5 (39.3-133.7)
.001
1 [Reference]
.001
2 874 39.7 (25.6-53.8) 0.64 (0.26-1.03)
3 898 16.9 (13.0-20.9) 0.33 (0.14-0.52)
4 324 9.3 (6.6-11.9) 0.23 (0.09-0.36)
Very likely 116 3.7 (2.8-4.7) 0.13 (0.06-0.20)
No response 73d 24.3 (3.2-45.5) 0.27 (0.00-0.58)
(continued)
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Female physicians had significantly higherNNEs than
did male physicians, but there was no difference be-
tween overseas- and Australian-trained physicians. No
other physician characteristics were retained in the fi-
nal model (Table 2). The physician’s assessment of the
likelihood ofmalignancywas strongly associatedwith the
NNE estimates for pigmented lesions: only 4% of pig-
mented lesionswere initially diagnosed as being very likely
to be malignant, and these composed 20% of the mela-
nomas; in contrast, 53% of those initially diagnosed as
not at all likely to be malignant (score of 1 or 2) com-
posed 20%.
Increased patient pressure was significantly associ-
atedwith higherNNEs, although the patternwas not con-
sistent across categories. Higher NNEs for pigmented le-
sions were also associated with initial biopsy rather than
excision, an excision site on the head or chest, those from
female patients, and those from the young (Table 2).
COMMENT
This study found that, for more than 8000 nonpig-
mented skin lesions excised or biopsied by primary care
physicians in Queensland, a mean of 1.5 nonpigmented
lesions were excised or biopsied for 1 confirmed NMSC.
For nearly 3000 pigmented lesions, primary care physi-
cians excised or biopsied nearly 20 pigmented lesions for
1 confirmedmelanoma. Estimates of NNE for pigmented
and nonpigmented lesions varied substantially according
to physician, patient, and lesion characteristics.
OTHER STUDIES
The overall NNE estimate of 20 for melanomas in this
study of primary care physicians was higher than those
reported for referral-based practices in Australia and in-
Table 2. Associations Among Various Physician-, Lesion-, and Patient-Related Characteristics and the NNE:
Melanomas vs All Pigmented Lesions (cont)
Variable and Categories
Pigmented
Lesions, No.
NNE Estimates
(95% CI)a P Value
Adjusted NNE Ratios
(95% CI)b P Value
Lesion-Related Characteristics
Patient pressure to excisec
No pressure 1045 12.6 (9.9-15.3)
.001
1 [Reference]
.001
2 315 35.0 (16.5-53.5) 2.61 (1.18-4.03)
3 470 16.8 (11.6-22.0) 1.18 (0.70-1.67)
4 419 29.9 (16.2-43.6) 2.37 (1.36-3.38)
Strong pressure 599 42.8 (24.9-60.7) 2.41 (1.40-3.41)
No response 129d 32.3 (10.5-54.0) 2.38 (0.00-4.76)
Initiatedc
By physician 651 14.2 (10.2-18.1)
.04
1 [Reference]
.94
Patient: primary reason 1972 21.2 (17.2-25.2) 1.02 (0.73-1.31)
Patient: secondary reason 205 18.6 (7.7-29.6) 1.19 (0.42-1.82)
No response 149d 74.5 (1.7-147.3) 4.81 (0.00-9.76)
Examination typed
Whole body 1450 21.3 (17.2-25.4)
.45 Not in final model NAPart body 299 19.9 (10.6-29.2)
Specific lesions 1179 17.6 (13.1-22.1)
Excision typed
Excision 1908 14.1 (11.8-16.5)
.001
1 [Reference]
.001
Biopsy 1054 62.0 (39.1-84.9) 5.91 (3.68-8.15)
Site
Head 614 21.9 (15.3-28.6)
.001
1 [Reference]
.001
Arm 552 12.3 (9.4-15.1) 0.67 (0.44-0.90)
Leg 465 20.2 (13.4-27.0) 0.80 (0.47-1.14)
Chest 421 52.6 (27.5-77.7) 2.55 (0.97-4.11)
Back 925 19.3 (14.2-24.4) 1.10 (0.69-1.51)
Patient-Related Characteristics
Sexd
Male 1459 14.6 (11.7-17.5)
.001
1 [Reference]
.02
Female 1512 29.1 (22.5-35.7) 1.37 (1.00-1.74)
Age, yd
50 1423 37.4 (26.3-48.6)
.001
2.54 (1.67-3.41)
.001
50 1550 13.6 (11.1-16.0) 1 [Reference]
Abbreviations: CI, confidence interval; CPD, continuing professional development; FRACGP, Fellow of the Royal Australian College of General Practitioners;
NA, not applicable; NNE, number of pigmented lesions needed to excise or biopsy.
aFor pigmented lesions, the NNE is the number of excisions or biopsies of lesions divided by the number of melanomas excised.
bRatios reflect the NNE in the specific category divided by the NNE in the reference category. The NNE ratios are adjusted for all other variables in the table,
except where specified. Variables were deleted from the multivariate model in a backward selection process based on P .25.
cThe “no response” category was not included in the tests of statistical significance.
dThe number of pigmented lesions do not total 2977 for some categories because of incomplete records: for examination type there were 49 records with
missing values; for excision type, 15 records; for sex, 6 records; and for age, 4 records.
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ternationally, with estimates of 16 from a referral-based
pigmented lesion clinic in theUnitedKingdom,12 whereas
estimates for dermatologists are lower, ranging from 7
to 13 in Australia8,26 and 6 in Italy.11 The NNE of 20 was,
however, lower than that in most other Australian stud-
ies of primary care physicians, with NNE estimates of 29
to 31.8,14,21 A separate Queensland study27 of rural FMPs
reported baseline NNE estimates for melanomas of 16,
and it could be that these lowerNNE estimates inQueens-
land reflect the high incidence of melanoma and the
greater exposure physicians have to diagnosing pig-
mented lesions.
There are few other published estimates for nonpig-
mented excised lesions. However, the present estimate
of 1.5 excisions of nonpigmented lesions for each con-
firmed NMSCwas similar to that reported recently from
a retrospective study22 of nonpigmented skin lesions in
Tasmania, Australia (NNE of 1.6).
The lower NNE estimates for nonpigmented lesions
vs pigmented lesions could reflect the higher preva-
lence of NMSC in the population compared with mela-
noma. It could also reflect the general difficulty of clini-
cally diagnosing melanoma because many of the typical
clinical features of melanoma also can be seen in benign
pigmented lesions.5
WHAT IS A GOOD NNE?
The ideal NNE is difficult to quantify. From the point of
view of fewer excisions of benign lesions and reducing
unnecessary morbidity, complications, adverse effects,
and cost, a lowerNNE ispreferred.However, a lowerNNE
risks malignant lesions being missed. This is of greater
importance for melanoma, with its greater potential to
cause mortality and associated medicolegal threats.11,12
Although the prevalence of missed melanomas from re-
ferral-based clinics is low,11,28 and medical inaction has
been suggested to account for only a small proportion of
the time until a melanoma is removed,29 we did not ex-
aminemissedmelanomas in this study. The desire to not
miss melanomas has to be balanced by the need to re-
duce health care costs of unnecessary excisions and bi-
opsies.9 Of course, NNE is not a measure of diagnostic
accuracy alone; it also depends on the prevalence of the
disease.8,14 Therefore, there can be no ideal standard for
NNE30 without also assessing sensitivity.31
PHYSICIAN CHARACTERISTICS
The finding that female physicians and those who were
trainedoverseashadhigherNNEsconfirms reports byother
researchers14 forpigmented lesions.Perhaps, given the lower
skincancer incidence incountriesother thanAustralia, over-
seas-trained physicians are taught less about skin cancer
during their initial training and obtain less experiencewith
diagnosing skin cancer before moving to practice in Aus-
tralia. The reasons for the female physician finding can also
be speculative only: increased priority on notmissingma-
lignant neoplasms or being presented with fewer malig-
nant lesions. We found that 49% of male physicians rated
the likelihood ofmalignancy as high (score of 4 or 5) com-
pared with 41% of female physicians.
LESION CHARACTERISTICS
Associationswith likelihoodofmalignancywere the stron-
gest observed in this study and suggest that clinical im-
pressions play an important and effective role in the de-
cision-making process. However, the finding that 20%
of histologically confirmedmelanomaswere initially con-
sidered to have low likelihood of malignancy highlights
the complexity of diagnosing pigmented skin lesions.
Increased levels of patient pressure (as perceived by
the physician) resulted in higherNNEs. This suggests that
patients have a generally lower ability to make the right
diagnosis or aremore anxious than their physician about
missing a cancer. This highlights the importance of tak-
ing into account pressure from the patient to excise skin
lesions when examining clinical diagnostic accuracy.
The higher proportion of benign lesions identified
through biopsy compared with excision was to be ex-
pected and confirms the role of biopsy as an additional
diagnostic tool. In contrast, we found that excisions were
used more when the physician was very confident that
the lesion was malignant. When we limited the analysis
to excised lesions only (results not presented), we found
similar associations to those already reported.
PATIENT CHARACTERISTICS
Higher NNEs in women and younger patients have been
reported previously.8,14,30 This may relate to the lower in-
cidence of skin cancer in these subgroups1,4 or to the in-
creased effect of other unmeasured factors, such as cos-
metic prompts.8 We found that 25.9% of excisions in
younger (50 years) patients were histologically be-
nign nevi compared with 3.6% in older patients. Al-
though the data on the relative prevalence of benign nevi
in young people compared with older people are incon-
clusive, the present data support the suggestion that nevi
are at least equally, if notmore, prevalent in young people
compared with older people. Thus, the lower incidence
of melanoma in young people means that more lesions
need to be excised to find a melanoma than in older
people.1,4
STRENGTHS AND LIMITATIONS
This large-scale prospective study was conducted in the
state with the highest reported incidence of skin cancer
in the world. We collected data on all skin lesions ex-
cised or biopsied by participating primary care physi-
cians during the study period. The prospective study de-
sign enabled a wider range of covariates to be assessed
than were available for previous studies using retrospec-
tive study designs.8,14,22,30,32,33 In particular, we mea-
sured physician perceptions of likelihood of malig-
nancy and level of patient pressure to excise for each
lesion, both of which were demonstrated to have strong
associations with the main outcome measures in this
study.
Thehigh response rate obtained among skin clinic phy-
sicians reduces the risk of selection bias in that group.
However, the lower response rate for FMPs, commen-
surate with the involvement required by FMPs who
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wanted to participate in this study,14,34 may indicate that
FMPs with an interest in skin cancer were more likely
to participate, which may have artificially reduced the
NNE estimates. In the absence of information on the clini-
cal interests of nonparticipating physicians, we cannot
exclude this possibility. We found no evidence of selec-
tion bias on the basis of age, sex, or simple measures of
clinical training. It is also possible that this prospective
study found an artificially reduced NNE due to a Haw-
thorne effect (changes in behavior due to being a study
participant).35 Histopathologic datawere provided by sev-
eral pathology laboratories, thus potentially increasing
the generalizability of the estimates compared with other
similar studies.8,32We combined in situ and invasivemela-
nomas in the estimates of NNE for pigmented lesions.
Although we acknowledge that they might be different
histopathologic entities, we suggest that the role of the
primary care physician is to identify melanomas as early
as possible, not to determine whether they are in situ or
invasive. We did, however, find that excluding in situ
melanomas from the set of malignant lesions increased
the NNE estimate for pigmented lesions. Finally, be-
cause this study considered excised lesions only, we could
not assess the sensitivity of diagnosis or the likelihood
that participating physicians missed malignant lesions.
IMPLICATIONS
This study found that clinical impressions of excised skin
lesions had a strong relationship with the number of be-
nign lesions excised for every malignancy. However, it
also demonstrated that many other factors contribute to
the decision whether to excise or biopsy a lesion. It is
likely that we could improve the effectiveness of future
training for primary care physicians in the clinical man-
agement of skin cancer by focusing on pigmented skin
lesions and addressing these nonclinical issues. Health
care practitioners inmany countries face pressures to re-
duce costs, and the increasing incidence of skin cancer
in most fair-skinned populations means that there will
continue to be a delicate balance between avoiding falsely
negative treatment decisions and reducing costs to the
health care system.
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Notable Notes
Techniques to Allay Anxiety During Pediatric Laser Procedures
A 6-year-old boy presented with a nevus simplex overlying
themiddle forehead that he has had since birth. He was being
treated with a 595-nm pulsed-dye laser every 4 weeks. We
use several measures in our pediatric dermatology clinic to
ease anxiety during laser treatments and other procedures in
children. In the video, which is available at the ArchivesWeb
site (http://www.archdermatol.com), you can see 4 different
techniques. First, lidocaine, 4%, cream (LMX) is applied to
the target area under occlusion at triage and then
is allowed to sit for at least 30 minutes before treatment with
the pulsed-dye laser is begun. Second, at least 1 parent re-
mains in the room, preferably close to the child, during the
procedure. Third, we position the child comfortably with a
firm but gentle hold on the target area. Finally, in the case of
laser treatments, we avoid using large goggles for eye protec-
tion in children and instead use layers of soft gauze, which
are held in place.
Mercedes E. Gonzalez, MD; Elizabeth Alvarez Connelly, MD;
Lawrence Schachner, MD
Video available online at
www.archdermatol.com
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